Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2023 · 10-Q
Revenue$8.93M$8.93M−22.1% vs Q2 2022 Net Income-$2.10M-$2.10MN/M vs Q2 2022 EPS Diluted-$0.69-$0.69N/M vs Q2 2022 Operating Income-$1,583,079N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$99,637−92.3% Margins · derivedOperating margin-17.7%−29.3 pt vs Q2 2022
Net margin-23.5%−30.1 pt vs Q2 2022
ended Jun 30, 2023 · filed Sep 21, 2023 · 83 d after period end